Sector
PharmaceuticalsOpen
₹13.23Prev. Close
₹13.5Turnover(Lac.)
₹2.69Day's High
₹13.23Day's Low
₹13.2352 Week's High
₹27.1552 Week's Low
₹5.75Book Value
₹1.43Face Value
₹1Mkt Cap (₹ Cr.)
579.31P/E
60.14EPS
0.22Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 10.95 | 3.91 | 1.57 | 1.57 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 46.69 | 21.38 | 14.78 | 14.03 |
Net Worth | 57.64 | 25.29 | 16.35 | 15.6 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 11.84 | 5.65 | 5.34 | 5.13 |
yoy growth (%) | 109.3 | 5.9 | 4.02 | 6.46 |
Raw materials | -3 | -0.99 | -0.95 | -1.04 |
As % of sales | 25.33 | 17.5 | 17.79 | 20.29 |
Employee costs | -4.4 | -1.96 | -1.27 | -1.09 |
Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | 0.06 | 0.72 | 0.94 | 1.05 |
Depreciation | -1.47 | -0.96 | -0.73 | -0.46 |
Tax paid | -0.13 | -0.26 | -0.42 | -0.55 |
Working capital | 0.39 | 1.47 | 0.26 | 0.19 |
Other operating items |
Y/e 31 Mar | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 109.3 | 5.9 | 4.02 | 6.46 |
Op profit growth | -6.61 | 2.11 | 10.28 | 24.06 |
EBIT growth | -90.08 | -26.76 | -6.95 | 15.17 |
Net profit growth | -92.29 | -12.12 | 4.55 | 321.93 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.35 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493.2 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,483.15 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.4 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,167.95 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Dakshesh Shah
Executive Director
Payal Mehta
Independent Director
Bhoomiben Patel
Independent Director
Sarjeevan Singh
Independent Director
Sonal Deepalbhai Gandhi
Whole Time Director
Sanskruti Patel
Whole Time Director
Dhruvin Shah
Independent Director
Pinki Nirmal Sagar
Whole Time Director
Anar Jayesh Patel
Independent Director
Jitendra shah
Company Sec. & Compli. Officer
Arpita Kabraa
Independent Director
Ritu Kapoor
Whole Time Director
Sheetal Shah
3 rd Floor Dev House,
Opp WIAA Office Judges Bungalo,
Gujarat - 380054
Tel: 91-079-66522247/27498515
Website: http://www.shukrapharmaceuticals.com
Email: info@shukrapharmaceuticals.com
9 ShivShakti Indl Es,
J R Boricha Marg, Lower Parel,
Mumbai - 400 011
Tel: 91-22-23016761/8261
Website: -
Email: -
Summary
Shukra Pharmaceuticals Limited (Formerly known Relish Pharmaceuticals Limited) was established in March, 1993 and later on the Company name was changed from Relish Pharmaceuticals Limited to Shukra P...
Read More
Reports by Shukra Pharmaceuticals Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.